人工智能用于低剂量CT肺癌筛查:不同使用场景的比较
该回顾性研究基于366例低剂量CT肺癌筛查者,模拟AI作为助手、预筛或后备三种使用场景。结果显示AI作为预筛可降低召回率、缩短阅片时间并提高特异度,且净获益高于无AI;AI作为助手净获益最低。
要点
- AI预筛场景下召回率20.8%,低于无AI的22.1%,特异度90.3%高于无AI的88.8%。
- AI作为助手场景召回率30.3%高于无AI的22.1%,特异度81.1%低于无AI的88.8%。
- 仅AI预筛场景净获益高于无AI,AI作为助手净获益最低。
核心结论
- 不同AI实施方式产生不同结局,研究结果支持将AI作为预筛场景。
研究设计与样本
- 回顾性研究,纳入366例(358男,8女,平均年龄64岁)于2017年5月至2017年12月接受低剂量CT检查者,检查由5名阅片者之一在有无商业AI计算机辅助检测工具两种情况下判读,由一组胸部放射科医师确定参考标准。
诊断标准与关键数值
- 无AI判读:召回率22.1%,结节敏感度64.2%,检查特异度88.8%,平均判读时间164秒。
- AI作为助手:召回率30.3%(p < .001),检查特异度81.1%,结节敏感度64.8%(p = .86),平均判读时间161秒(p = .48)。
- AI作为预筛:召回率20.8%(p = .02),平均判读时间143秒(p = .001),检查特异度90.3%(p = .04),结节敏感度62.9%(p = .16)。
- AI作为后备:召回率33.6%(p < .001),检查敏感度66.4%(p < .001),平均判读时间225秒(p = .001),检查特异度79.9%(p < .001)。
- 决策曲线分析:各场景中仅AI作为预筛的净获益高于无AI判读,AI作为助手的净获益最低。
临床应用与阅片要点
- 作者结论支持将AI作为预筛场景,即放射科医师仅判读AI结果阳性的低剂量CT检查,可在保持敏感度的同时减少放射科医师工作量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Artificial intelligence (AI) tools for evaluating low-dose CT (LDCT) lung cancer screening examinations are used predominantly for assisting radiologists' interpretations. Alternate utilization scenarios (e.g., use of AI as a prescreener or backup) warrant consideration. OBJECTIVE. The purpose of this study was to evaluate the impact of different AI utilization scenarios on diagnostic outcomes and interpretation times for LDCT lung cancer screening. METHODS. This retrospective study included 366 individuals (358 men, 8 women; mean age, 64 years) who underwent LDCT from May 2017 to December 2017 as part of an earlier prospective lung cancer screening trial. Examinations were interpreted by one of five readers, who reviewed their assigned cases in two sessions (with and without a commercial AI computer-aided detection tool). These interpretations were used to reconstruct simulated AI utilization scenarios: as an assistant (i.e., radiologists interpret all examinations with AI assistance), as a prescreener (i.e., radiologists only interpret examinations with a positive AI result), or as backup (i.e., radiologists reinterpret examinations when AI suggests a missed finding). A group of thoracic radiologists determined the reference standard. Diagnostic outcomes and mean interpretation times were assessed. Decision-curve analysis was performed. RESULTS. Compared with interpretation without AI (recall rate, 22.1%; per-nodule sensitivity, 64.2%; per-examination specificity, 88.8%; mean interpretation time, 164 seconds), AI as an assistant showed higher recall rate (30.3%; p < .001), lower per-examination specificity (81.1%), and no significant change in per-nodule sensitivity (64.8%; p = .86) or mean interpretation time (161 seconds; p = .48); AI as a prescreener showed lower recall rate (20.8%; p = .02) and mean interpretation time (143 seconds; p = .001), higher per-examination specificity (90.3%; p = .04), and no significant difference in per-nodule sensitivity (62.9%; p = .16); and AI as a backup showed increased recall rate (33.6%; p < .001), per-examination sensitivity (66.4%; p < .001), and mean interpretation time (225 seconds; p = .001), with lower per-examination specificity (79.9%; p < .001). Among scenarios, only AI as a prescreener demonstrated higher net benefit than interpretation without AI; AI as an assistant had the least net benefit. CONCLUSION. Different AI implementation approaches yield varying outcomes. The findings support use of AI as a prescreener as the preferred scenario. CLINICAL IMPACT. An approach whereby radiologists only interpret LDCT examinations with a positive AI result can reduce radiologists' workload while preserving sensitivity.
引用
- Lee M, Hwang EJ, Lee JH, et al. Artificial Intelligence for Low-Dose CT Lung Cancer Screening: Comparison of Utilization Scenarios. AJR Am J Roentgenol. 2025. PMID: 40237429. doi:10.2214/AJR.25.32829
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。